Sanofi: Qfitlia Approval A Bright Spot As Landscape Darkens For European Pharma
Sanofi's Qfitlia gains FDA approval, offering fewer injections in hemophilia care. Check out my recommendation for SNY stock.
pharmaphorum1d
Why the drug pricing debate is focused on insulin
The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo Nordisk’s Novolog (insulin aspart) and Eli Lilly’s Humalog (insulin lispro) by 2024.
pharmaphorum4d
Ablynx and Sanofi sign potential 2.4bn euro R&D deal
The Paris-headquartered pharma firm is suffering from dwindling sales of its blockbuster Lantus (insulin glargine), and has missed out twice on big M&A deals in the last year. It is now tapping ...
Medscape4d
Room-temperature Storage of Medications Labeled for Refrigeration
Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis ...
Medscape2d
Room-temperature Storage of Medications Labeled for Refrigeration
28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...
Healthline5d
Invokana Interactions: Alcohol, Medications, and Others
Invokana (canagliflozin) has potential interactions with alcohol, other medications, and some supplements. For example, Invokana can interact with lithium and other diabetes drugs. Invokana is ...
This is Money2d
Best cash Isa savings rates tables 2025: Easy access and fixed rates
This is Money's best cash Isa tables are updated as new deals arrive and highlight the top easy access and fixed rate Isas from banks and building societies. Our cash Isa rate tables are compiled ...